AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

$ 24.00

4.5
(337)
In stock
Description

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs

FDA accepts first AI algorithm to drug development tool pilot

RuntimeError: Torch is not able to use GPU; add --skip-torch-cuda-test to COMMANDLINE_ARGS variable to disable this check · Issue #349 · Stability-AI/stablediffusion · GitHub

Beyond Discovery: Leveraging AI To Accelerate Clinical Trials

Branded Content Archives · TechNode

D-FW biotech firm completes “first ever” AI clinical trial

Contemporary Competitive Scenario: Analyzing Roche's Emergent Product, Trontinemab

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

How does Claude, the new LLM from Anthropic compare to ChatGPT? A serious contender, by Cerebrium

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes